3 February 2012 - Belgian medical equipment and services specialist Arseus (EBR:RCUS) is expected to have reached its revenue target for 2011, according to average analyst estimates ahead of the release of annual results on Tuesday.

CEO Gert van Jeveren forecast in October an annual revenue growth of between 14% and 18% in 2011.

The analyst consensus, published yesterday, bets on a 16% increase to EUR493m (USD649.6m). Net profit is seen to have improved by over 40% to EUR32.2m.

Arseus benefited last year from two large acquisitions in Brazil, boosting the operations of its key Fagron division, which supplies pharmacies.

(EUR1 = USD1.315)